Breast Imaging Market to Reach US$3,905.2 Million by 2022, with a CAGR of 7.6%: Coherent Market Insights
The global Breast Imaging Market is projected to reach a value of US$3,905.2 million by 2022, exhibiting a CAGR of 7.6% during the forecast period 2022-2030. The market report published by Coherent Market Insights provides insights into various segments of the breast imaging industry. Breast imaging products offer several advantages, including early detection of breast cancer, improved diagnostic accuracy, and non-invasive procedures. The need for these products is driven by the rising prevalence of breast cancer worldwide, coupled with increasing awareness about the importance of early detection. The market is also influenced by technological advancements, such as the development of digital breast tomosynthesis and molecular breast imaging, which further enhance the accuracy and reliability of breast cancer diagnosis.
Market Key Trends:
One key trend in the breast imaging market is the increasing adoption of 3D breast tomosynthesis. This technology offers greater detail and clarity in breast imaging, leading to improved diagnostic accuracy compared to traditional 2D mammography. It allows radiologists to view multiple image slices of the breast, reducing false positives and improving the detection of small tumors. 3D breast tomosynthesis is particularly beneficial for women with dense breast tissue, as it helps in overcoming the challenges of overlapping structures. The growing preference for more effective and accurate breast imaging techniques is contributing to the market growth of 3D breast tomosynthesis across the globe.
Note: The report also includes key players in the market, such as GE Healthcare, Siemens Healthcare GmbH, Seno Medical, Koninklijke Philips N.V., Fujifilm Holdings Corporation, Hologic, Inc., Aurora Imaging Technologies, Inc., Canon Inc., Dilon Technologies, Inc
The breast imaging market can be segmented into mammography, breast ultrasound, breast MRI, molecular breast imaging, and other imaging technologies. Among these segments, mammography dominates the market, accounting for the largest share. Mammography is a commonly used method for breast cancer screening, diagnosis, and monitoring, making it the most widely adopted breast imaging modality. It offers several advantages, such as high sensitivity, ability to detect microcalcifications, and cost-effectiveness.
The global Breast Imaging Market Share is expected to witness high growth, exhibiting a CAGR of 7.6% over the forecast period. This growth can be attributed to the increasing prevalence of breast cancer worldwide and the rising demand for early detection and accurate diagnosis. The market is driven by factors such as technological advancements in imaging modalities, increasing awareness about breast cancer screening programs, and favorable reimbursement policies for breast imaging procedures.
In terms of regional analysis, North America dominates the breast imaging market, accounting for the largest share. This can be attributed to the high prevalence of breast cancer in the region, well-established healthcare infrastructure, and the availability of advanced imaging technologies. Europe is also a significant market for breast imaging, driven by the increasing adoption of digital mammography systems and government initiatives for breast cancer screening.
Key players operating in the breast imaging market include GE Healthcare, Siemens Healthcare GmbH, Seno Medical, Koninklijke Philips N.V., Fujifilm Holdings Corporation, Hologic, Inc., Aurora Imaging Technologies, Inc., Canon Inc., Dilon Technologies, Inc., Leica Biosystems Nussloch GmbH (Danaher), Carestream Health, Avante Health Solutions, Hitachi, Ltd, PLANMED OY, and Barco. These companies focus on product innovation, strategic collaborations, and mergers and acquisitions to maintain a competitive edge in the market.